T. Rowe Price Blue Chip Growth Portfolio LLY Holdings History
T. Rowe Price Blue Chip Growth Portfolio's Eli Lilly and Co Holding Summary
As of 2025-03-31, T. Rowe Price Equity Series, Inc. held 90,519.00 shares of Eli Lilly and Co(LLY), totaling $74.76 Mil. This investment constitutes 3.65% of their stock portfolio, and T. Rowe Price Equity Series, Inc. now holds 0.01% of the outstanding Eli Lilly and Co(LLY) stock.
The initial trade took place in 2019Q3. And since then T. Rowe Price Blue Chip Growth Portfolio has made 4 purchases of LLY, at an average price of $275.25, for a total of 116,530.00 shares. In addition, there have been 8 sales at an average price of $571.10 for 26,011.00 shares. Based on historical transaction data and LLY's current price of $789.80, T. Rowe Price Blue Chip Growth Portfolio's estimated gain on his LLY holdings is $54.27 Mil, reflecting a 169.20% gain to date.
T. Rowe Price Blue Chip Growth Portfolio LLY ($789.80) Holding Chart
T. Rowe Price Blue Chip Growth Portfolio LLY ($789.80) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1